The MAPT A152T rare variant is considered a risk factor for tauopathies including FTLD-tau and AD [27], and we included both of the patients with this variant available within the UCSF Neurodegenerative Disease Brain Bank. The gene discussed is MAPT; the disease is tauopathy.